Properties of myelin altered peptide ligand cyclo(87-99)(Ala91,Ala96)MBP87-99 render it a promising drug lead for immunotherapy of multiple sclerosis.
Deraos G, Rodi M, Kalbacher H, Chatzantoni K, Karagiannis F, Synodinos L, Plotas P, Papalois A, Dimisianos N, Papathanasopoulos P, Gatos D, Tselios T, Apostolopoulos V, Mouzaki A, Matsoukas J.
Deraos G, et al. Among authors: mouzaki a.
Eur J Med Chem. 2015 Aug 28;101:13-23. doi: 10.1016/j.ejmech.2015.06.015. Epub 2015 Jun 17.
Eur J Med Chem. 2015.
PMID: 26112377